Literature DB >> 9854023

Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations.

M W Coughtrie1, R A Gilissen, B Shek, R C Strange, A A Fryer, P W Jones, D E Bamber.   

Abstract

Sulphation, catalysed by members of the sulphotransferase (SULT) enzyme family, is an important component of the body's chemical defence mechanism, but also acts to bioactivate mutagens such as hydroxylated aryl and heterocyclic amines. A major human sulphotransferase, SULT1A1 (P-PST), metabolizes and/or bioactivates many drugs, iodothyronines and hydroxylated aromatic amines. The enzyme activity varies widely within the population and is under genetic control. We have developed an assay detecting a G-->A transition in SULT1A1 that causes an Arg213-->His substitution associated with low SULT activity and altered enzyme properties, and have used it to assess the SULT1A1 genotype in Caucasian (n=293) and African (Nigerian, n=52) populations. We show that the mutant SULT1A1*2 allele is present at frequencies of 0.321 and 0.269 in the Caucasian and African populations respectively. We also demonstrate a significant age-related difference in SULT1A1 genotype within our Caucasian population, with increasing incidence of SULT1A1*1 homozygosity and decreasing incidence of SULT1A1*2 homozygosity with increasing age, indicating a potential association of SULT1A1*1 allozyme(s) with protection against cell and/or tissue damage during aging.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9854023      PMCID: PMC1219934     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

Review 1.  Interethnic variation of drug metabolism.

Authors:  W Kalow
Journal:  Trends Pharmacol Sci       Date:  1991-03       Impact factor: 14.819

Review 2.  Molecular enzymology of human liver cytosolic sulfotransferases.

Authors:  C N Falany
Journal:  Trends Pharmacol Sci       Date:  1991-07       Impact factor: 14.819

3.  Identification of two human brain aryl sulfotransferase cDNAs.

Authors:  X Zhu; M E Veronese; C C Bernard; L N Sansom; M E McManus
Journal:  Biochem Biophys Res Commun       Date:  1993-08-31       Impact factor: 3.575

4.  Polymorphism at the glutathione S-transferase GSTM1 locus: a study of the frequencies of the GSTM1 A, B, A/B and null phenotypes in Nigerians.

Authors:  L Zhao; J Alldersea; A Fryer; A Tighe; B Ollier; W Thomson; P Jones; R Strange
Journal:  Clin Chim Acta       Date:  1994-02       Impact factor: 3.786

Review 5.  Sulfonation in chemical carcinogenesis--history and present status.

Authors:  J A Miller
Journal:  Chem Biol Interact       Date:  1994-06       Impact factor: 5.192

6.  Sulfation of aromatic hydroxamic acids and hydroxylamines by multiple forms of human liver sulfotransferases.

Authors:  R A Gilissen; K J Bamforth; J F Stavenuiter; M W Coughtrie; J H Meerman
Journal:  Carcinogenesis       Date:  1994-01       Impact factor: 4.944

7.  The human phenolsulphotransferase polymorphism is determined by the level of expression of the enzyme protein.

Authors:  A L Jones; R C Roberts; M W Coughtrie
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

8.  Mapping of the phenol sulfotransferase gene (STP) to human chromosome 16p12.1-p11.2 and to mouse chromosome 7.

Authors:  T P Dooley; R D Obermoeller; E H Leiter; H D Chapman; C N Falany; Z Deng; M J Siciliano
Journal:  Genomics       Date:  1993-11       Impact factor: 5.736

9.  Sequence analysis and expression of the cDNA for the phenol-sulfating form of human liver phenol sulfotransferase.

Authors:  T W Wilborn; K A Comer; T P Dooley; I M Reardon; R L Heinrikson; C N Falany
Journal:  Mol Pharmacol       Date:  1993-01       Impact factor: 4.436

10.  Acetylation polymorphism and prevalence of colorectal adenomas.

Authors:  N M Probst-Hensch; R W Haile; S A Ingles; M P Longnecker; C Y Han; B K Lin; D B Lee; G T Sakamoto; H D Frankl; E R Lee
Journal:  Cancer Res       Date:  1995-05-15       Impact factor: 12.701

View more
  27 in total

1.  Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population.

Authors:  Samar I Hamdy; Masahiro Hiratsuka; Kaori Narahara; Naomi Endo; Mervat El-Enany; Nadia Moursi; Mohammed S-E Ahmed; Michinao Mizugaki
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

2.  Genetic polymorphisms and linkage disequilibrium of sulfotransferase SULT1A1 and SULT1A2 in a Korean population: comparison of other ethnic groups.

Authors:  Kyoung-Ah Kim; Sook-Young Lee; Pil-Whan Park; Jong-Myung Ha; Ji-Young Park
Journal:  Eur J Clin Pharmacol       Date:  2005-08-26       Impact factor: 2.953

Review 3.  Pharmacogenetics in drug regulation: promise, potential and pitfalls.

Authors:  Rashmi R Shah
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-08-29       Impact factor: 6.237

4.  The effects of endoxifen and other major metabolites of tamoxifen on the sulfation of estradiol catalyzed by human cytosolic sulfotransferases hSULT1E1 and hSULT1A1*1.

Authors:  Edwin J Squirewell; Michael W Duffel
Journal:  Drug Metab Dispos       Date:  2015-03-27       Impact factor: 3.922

5.  A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease.

Authors:  Luca Miele; Valentina Dall'armi; Consuelo Cefalo; Bojan Nedovic; Dario Arzani; Rosarita Amore; Gianlodovico Rapaccini; Antonio Gasbarrini; Walter Ricciardi; Antonio Grieco; Stefania Boccia
Journal:  Genes Nutr       Date:  2014-01-09       Impact factor: 5.523

6.  Association between the SULT1A1 Arg213His polymorphism and the risk of bladder cancer: a meta-analysis.

Authors:  Chih-Ming Su; Mei-Chieh Chen; I-Chan Lin; Hsin-An Chen; Ming-Te Huang; Chih-Hsiung Wu; Kun-Hung Shen; Yuan-Hung Wang
Journal:  Tumour Biol       Date:  2014-04-25

Review 7.  Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes.

Authors:  Deirdre P Cronin-Fenton; Timothy L Lash
Journal:  Expert Rev Clin Pharmacol       Date:  2011-05       Impact factor: 5.045

8.  Sulfotransferase 1A1 Arg(213)His polymorphism and prostate cancer risk.

Authors:  Serdal Arslan; Yavuz Silig; Hatice Pinarbasi
Journal:  Exp Ther Med       Date:  2011-08-12       Impact factor: 2.447

9.  A case-control study investigating the role of sulfotransferase 1A1 polymorphism in head and neck cancer.

Authors:  Stefania Boccia; Gabriella Cadoni; Giuseppe La Torre; Dario Arzani; Mariangela Volante; Caterina Cattel; Francesco Gianfagna; Gaetano Paludetti; Giovanni Almadori; Gualtiero Ricciardi
Journal:  J Cancer Res Clin Oncol       Date:  2006-03-31       Impact factor: 4.553

10.  Susceptibility to Helicobacter pylori infection: results of an epidemiological investigation among gastric cancer patients.

Authors:  Nikola Panic; Elena Mastrostefano; Emanuele Leoncini; Roberto Persiani; Dario Arzani; Rosarita Amore; Riccardo Ricci; Federico Sicoli; Stefano Sioletic; Milutin Bulajic; Domenico D' Ugo; Walter Ricciardi; Stefania Boccia
Journal:  Mol Biol Rep       Date:  2014-02-14       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.